Acute Necrotizing Encephalopathy Post SARS-CoV-2 Infection in an Adult Patient: Case Report

Itzel Ariadna Hernández-Dehesa1, José Alfonso Alvarez-Castro2, Keren Magaly Aguilar-Hidalgo2

  • 1Department of Radiology, National Institute of Neurology and Neurosurgery "Manuel Velasco Suarez", Mexico City, Mexico.

Insights

This study details a rare case of acute necrotizing encephalopathy in an adult following SARS-CoV-2 infection. MRI revealed characteristic brain lesions, highlighting the need for specific imaging sequences in diagnosis.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Radiology

Background:

  • Acute necrotizing encephalopathy (ANE) is a rare neurological disorder.
  • SARS-CoV-2 infection has been linked to various neurological complications.
  • Adult ANE cases are exceptionally rare, posing diagnostic challenges.

Observation:

  • A 26-year-old male with a history of medulloblastoma presented with SARS-CoV-2 positive cerebrospinal fluid.
  • The patient exhibited persistent mixed dysarthria (flaccid and hypokinetic).
  • Neurological examination revealed the patient was awake, oriented, and able to maintain attention.

Findings:

  • Magnetic Resonance Imaging (MRI) demonstrated multifocal hemorrhagic lesions with edema.
  • Lesions were predominantly in the thalami, with extensions to the internal capsule and brainstem.
  • Specific MRI sequences, including susceptibility-weighted imaging (SWI), are crucial for diagnosis.

Implications:

  • This case underscores the potential for rare neurological sequelae following SARS-CoV-2 infection in adults.
  • Early and accurate diagnosis of ANE is critical for patient management.
  • The inclusion of advanced MRI sequences like SWI is recommended for diagnosing ANE.

Related Concept Videos

Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
155
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
291
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
169
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
254
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
235